“There’s a healthy debate in the North American medical field currently regarding whether it is useful to screen and decolonize patients for MRSA in this way prior to hospital admission. Detractors cite the costs of screening and subsequent measures as prohibitive to the potential benefits of eliminating a few infections. Proponents wave pharmacoeconomic studies suggesting that the prevention of just a few major infections per year in a hospital can recoup the investment in screening equipment and effort. So what’s the truth?”
So what are your thoughts on the subject?